Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $150,980 - $248,320
2,000 New
2,000 $248,000
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $105,287 - $140,309
-1,300 Reduced 56.52%
1,000 $427,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $129,033 - $204,201
-2,700 Reduced 54.0%
2,300 $619,000
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $139,200 - $194,600
5,000 New
5,000 $749,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.